Neurology
Found 22 results
Filters: Author is Kaunzner, Ulrike W  [Clear All Filters]
2025
Diaz P, Nealon NE, Kaunzner UW.  2025.  Pain and Headache in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.. Curr Pain Headache Rep. 29(1):39.
2024
Michaelson NM, Rúa SH, Kaunzner UW, Marcille M, Pliska-Bloch I, Markowitz K, Nguyen TD, Gauthier SA.  2024.  Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis.. Ann Clin Transl Neurol.
2023
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen H-C, Carruthers R et al..  2023.  Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.. Proc Natl Acad Sci U S A. 120(3):e2207291120.
2022
Marcille M, Rúa SHurtado, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW, Nealon N, Perumal JS, Zexter L, Zinger N et al..  2022.  Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.. Sci Rep. 12(1):4411.
Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA.  2022.  Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.
Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD.  2022.  Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.. J Neuroimaging. 32(4):667-675.
2021
Han CYoung, Tarr AM, Gewirtz AN, Kaunzner UW, Roy-Burman P, Cutler TS, MacGowan DJl.  2021.  Brachial plexopathy as a complication of COVID-19.. BMJ Case Rep. 14(3)
Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S et al..  2021.  QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.. Ann Clin Transl Neurol. 8(4):877-886.
2020
Telesford KM, Kaunzner UW, Perumal J, Gauthier SA, Wu X, Diaz I, Kruse-Hoyer M, Engel C, Marcille M, Vartanian T.  2020.  Black African and Latino/a identity correlates with increased plasmablasts in MS.. Neurol Neuroimmunol Neuroinflamm. 7(1)
Pandya S, Kaunzner UW, Rúa SMHurtado, Nealon N, Perumal J, Vartanian T, Nguyen TD, Gauthier SA.  2020.  Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.. J Neuroimaging. 30(4):537-543.
Kang Y, Rúa SMilena Hur, Kaunzner UW, Perumal J, Nealon N, Qu W, Kothari PJ, Vartanian T, Kuceyeski A, Gauthier SA.  2020.  A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis.. Mol Imaging Biol.
2019
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
2018
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
2017
Kaunzner UW, Salamon E, Pentsova E, Rosenblum M, Karimi S, Nealon N, Lavi E, Jamieson DG.  2017.  An Acute Disseminated Encephalomyelitis-Like Illness in the Elderly: Neuroimaging and Neuropathology Findings.. J Neuroimaging. 27(3):306-311.
Kaunzner UW, Al-Kawaz M, Gauthier SA.  2017.  Defining Disease Activity and Response to Therapy in MS.. Curr Treat Options Neurol. 19(5):20.
Kaunzner UW, Gauthier SA.  2017.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.. Ther Adv Neurol Disord. 10(6):247-261.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
2016
Parikh NS, Khazanova D, Moya A, Kaunzner UW, Allen BB, Navi BB.  2016.  Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction.. Neurology. 87(5):e49-53.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.  2016.  A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
2015
Glennon E, Kaunzner UW, Gagnidze K, McEwen BS, Bulloch K.  2015.  Pituitary dendritic cells communicate immune pathogenic signals.. Brain Behav Immun. 50:232-240.
2012
Kaunzner UW, Miller MM, Gottfried-Blackmore A, Gal-Toth J, Felger JC, McEwen BS, Bulloch K.  2012.  Accumulation of resident and peripheral dendritic cells in the aging CNS.. Neurobiol Aging. 33(4):681-693.e1.